Additionally, the presence of large chains such as CVS Health, Walgreens Boots Alliance, Inc., Walmart Stores, Inc, and Rite Aid Corp is supporting the segment’s growth. The presence of a robust product portfolio and diverse distribution network of these players across key applications such as immunology, oncology, and vaccines propel their company share in the market. By route of administration, the injections segment will gain a significant share of the market over the studied period.
US Prescription Drugs Market Growth Factors
The branded segment dominated the pharmaceutical market with a revenue share of 66.86% in 2024. The adults segment held the largest market share of 62.84% in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. The adult population aged from years holds the largest share in the total population and are the major consumer of prescription medicine. According to CDC,in U.S., around 69.0% and in Canada, around 65.5%, accounting to nearly 7 in 10 persons aged used at least one prescription drug. The most commonly used drug among the adult population includes lipid-lowering drugs, ACE inhibitors, analgesics, and antidepressants. The rising awareness among the adult population regarding diseases and available medicine is further propelling demand for effective therapeutics subsequently fueling growth of overall U.S.
To treat various ailments, tablets may contain a single active ingredient or a mixture of active compounds. Additionally, customers frequently choose tablets for self-medication since they are a practical and simple dosing type. They may be taken without water in some situations due to their discreet and portable design, which makes them popular. MS-13 and the 18th Street gang are notorious for their contributions and influence over drug trafficking throughout Latin America.
The growth in over the counter (OTC) medicine use in this category can be attributed to the rise in the number of persons who are afflicted with cough, cold, and flu. As a last option, consumers rely on over-the-counter medications for cough, cold, or flu symptoms. Similar to the overall small molecule drug and biological productmarkets, we saw that in the specialty market, there was more competitionamong small molecule drugs than among biological products. We alsoobserved a greater percentage increase in biological products with asingle manufacturer over time, 44 percent, relative to a 19 percentincrease among small molecule drugs. However, the total number of newspecialty molecules with only one manufacturer was similar, 50 and 43for biological products and small molecule drugs, respectively. In addition, we examine a subset of “specialty”drugs (as opposed to “traditional” or“non-specialty” drugs) and then focus on the top 10 percent ofdrugs based on price, i.e., “highest priced drugs”, most, butnot all, of which are specialty drugs.
Key Takeaways:
By route of administration, the parenteral (injectable) segment is expected to grow fastest during the projected period. Its robust delivery of medication into the bloodstream and reliability are driving the growth of this segment in the drugs market. The global ophthalmic drugs market size is calculated at USD 38.85 billion in 2024, grow to USD 42.23 billion in 2025, and is projected to reach around USD 89.47 billion by 2034, growing at a CAGR of 8.7% from 2025 to 2034.
Acquisitions of biotech firms and strategic alliances enable firms to accelerate pipeline development in key therapeutic areas such as oncology, rare diseases, and chronic conditions. Industry consolidation supports cost efficiencies, enhances R&D capabilities, and strengthens market positioning. The FDA approves patent and exclusivity protection for the branded drug developer to allow them to profit from their innovation and research for several years. However, once the patent has expired generic drugs can enter the market through a shortened FDA approval process. Generic medications need to meet the same quality, safety, and effectiveness standards as brands. Based on product type, other prescription drugs segment is expected to hold the maximum share prescription drugs market.
BioMarin’s product portfolio includes several orphan drugs, such as the mucopolysaccharidoses (MPS) group of disorders, and the company also has strong orphan drug pipeline candidates in various stages of clinical trials. The market is driven by escalated life expectancy, a rising population, and the increase in chronic conditions like diabetes and hypertension, along with advancing developments in drug development like biologics and biosimilars. Govement is supporting with its policies, such as the Production-Linked Incentive (PLI) scheme, bulk drug parks, and the National R&D Policy are also propelling demand for the drugs. One more significantly rising factor is that India is a leading provider of generic medicines, with inexpensive production facilities.
Age-related Macular Degeneration (AMD) Drugs Market 2025 North America Leads With 41% Share
- One main reasonthe generic drug market is expanding is the worldwide expiration of brandeddrug patents.
- Recently, in September 2024, the API Innovation Center received USD 14 million in strategic funding aimed at strengthening U.S. pharmaceutical independence.
- There have been eight launches to date in 2023, compared to 11 launches for the same period in 2022, with oncology accounting for 38% of product launches in 2023.
- In many instances, these prescription drug costs can lie in the range of USD 100, ,000, and the conditions are not even curative.
- Conventional medicine is characterized as a type of medicine that seeks to repress the causes of sickness, considers health as the absence of disease, diagnoses particular organ or tissue aberrations, and usually requires passive patient engagement in therapy.
I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter. Our premium consulting services are available for an additional fee is designed to help you gain a competitive edge. The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified). IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are.
INSTITUTE REPORT
These hairs usually help clean out mucus and dirt, but when they’re paralyzed by smoke, mucus can build up and cause more infections. Efforts to reduce smoking rates and address smoking-related respiratory diseases are crucial for public health. Smoking cessation programs, which help people quit smoking, are an essential part of these efforts. These programs may include counseling, support groups, and medications to help manage nicotine withdrawal symptoms.
Which Factors Driven The Growth Of The Ophthalmic Drugs Market?
We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report. Vipul Patil is a dynamic management consultant with 6 years of dedicated experience in the pharmaceutical industry. Known for his analytical acumen and strategic insight, Vipul has successfully partnered with pharmaceutical companies to enhance operational efficiency, cross broader expansion, and navigate the complexities of distribution in markets with high revenue potential. In terms of distribution channel, the market is segmented into retail pharmacies, hospital pharmacies & drug stores, and online pharmacies. This was owing to the limited number of patient visits to hospitals and low dispersion of prescriptions by healthcare professionals, further lowering the demand and adoption of these drugs.
World Drug Report 2024
Figure 3 shows thelevel of competition among specialty drugs in small molecule drug andbiological product markets, and both curves show an increase in theshare of single-manufacturer products. In total, there were 347specialty small molecule drugs in 2017 (19 percent of all small moleculedrugs), which increased to 434 by 2022 (24 percent of all small moleculedrugs). In 2022, 273 specialty small molecule drugs (63 percent) hadonly one manufacturer, 51 specialty small molecule drugs had 2-3manufacturers (12 percent), and 26 specialty small molecule drugs (6percent) had 4-5 manufacturers. The only competition category thatchanged noticeably, as a percentage share of the total, over the sampleperiod was the number of specialty small molecule drugs with 6+manufacturers, which increased from 49 drugs in 2017 to 84 drugs in2022, an increase of 71.4 percent. The cancer segment dominated the overall market, contributing to a revenue share of 17.07% in 2024. Pharmaceutical Market can be attributed to several key factors and trends such as, the rising global incidence of various types of cancer has led to an increased demand for innovative & effective treatments, driving significant investment and research in this area.
Quantities of the drug were then smuggled throughout the US.55 The international drug trade created political ties between the involved countries, encouraging the governments of the countries involved to collaborate and instate common policies to eradicate drug cartels. Cuba stopped being a center for transport of cocaine following the Cuban Revolution and the establishment of Fidel Castro’s communist government in 1959. In 1929, the Institutional Revolutionary Party (PRI) was formed to resolve the chaos resulting from the Mexican Revolution. Over time, this party gained political influence and had a major impact on Mexico’s social and economic policies.68 The party created ties with various groups as a power play in order to gain influence, and as a result created more corruption in the government. This political corruption obscured justice, making it difficult to identify violence when it related to drugs.78 By the 1940s, the tie between the drug cartels and the PRI had solidified. This arrangement created immunity for the leaders of the drug cartels and allowed drug trafficking to grow under the protection of the government officials.
The robust healthcare system of Germany is widely emphasizing the quality and safety of the patient, which demands a range of pharmaceutical products. By distribution channel, the online pharmacies segment is expected to grow fastest during the forecast period. This segment is experiencing demand due to contributing factors such as, it is convenience, approachability, and reasonable cost. Major drivers are increasing inteet adoption, accelerated usage of smartphones, and a preference for telehealth and online healthcare approaches.
Key factors that are driving the market growth include increasing chronic disease prevalence, rising geriatric population, increasing healthcare spending by government organizations globally, and extensive efforts to improve the affordability of pharmaceuticals. Based on type, the pure generic drugs segment dominated the market in 2024 and held more than half of the global market share, 51%. Therefore, the upper hand of the pure generic drugs segment is predicted to continue during the forecast period. The cost-effectiveness of these drugs and the growing adoption of pure generic drugs in developing countries primarily drive the segment’s growth. In addition, the patent expiration of several blockbuster drugs is anticipated to boost the segment’s growth rate. The quality issues of generic drugs are another significant challenge to the global market growth.
- Smoking makes the body’s defense system weaker, so smokers can quickly get respiratory infections like pneumonia and bronchitis.
- Cough and cold products have secured a leading position within the U.S. over the counter drugs market by capturing over 60% market share primarily because of their widespread use for routine respiratory symptoms.
- The reports revealed by the US National Library of Medicine and National Institutes of Health reveals that 96% of the patients reported taking prescription medicines within three days prior to chemotherapy.
- According to our prescription drugs industry analysis, the significant difference between generic and branded prescription drugs is the cost of the product.
- The subsequent section brings in the human element, exploring patient and physician perspectives that are crucial for market adoption.
In the U.S., generic pharmaceutical companies are responsible for manufacturing the medicines used in 9 out of 10 prescriptions that are dispensed. This highlights the significant role played by generic drugs in providing accessible and affordable healthcare options to the population. The U.S. healthcare system encourages the use of generic drugs through various policies and initiatives. Food and Drug Administration (FDA) has implemented programs to expedite the review and approval process for generic drugs, such as the Generic Drug User Fee Amendments (GDUFA). These programs aim to increase competition, reduce drug prices, and enhance the availability of generic drugs to patients. According to the Association for Accessible Medicines, approximately $2.9 trillion has been saved for patients and the U.S. healthcare system through the use of generics and biosimilars in the last decade.
